HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eric J Small Selected Research

apalutamide

2/2022Deep Prostate-specific Antigen Response following Addition of Apalutamide to Ongoing Androgen Deprivation Therapy and Long-term Clinical Benefit in SPARTAN.
1/2022Health-related Quality of Life at the SPARTAN Final Analysis of Apalutamide for Nonmetastatic Castration-resistant Prostate Cancer Patients Receiving Androgen Deprivation Therapy.
7/2021Association of Molecular Subtypes With Differential Outcome to Apalutamide Treatment in Nonmetastatic Castration-Resistant Prostate Cancer.
1/2021Blood Biomarker Landscape in Patients with High-risk Nonmetastatic Castration-Resistant Prostate Cancer Treated with Apalutamide and Androgen-Deprivation Therapy as They Progress to Metastatic Disease.
1/2021Apalutamide and Overall Survival in Prostate Cancer.
12/2020Efficacy and safety of apalutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a subgroup analysis of a randomized, double-blind, placebo-controlled, Phase-3 study.
1/2020Efficacy and Safety Exposure-Response Relationships of Apalutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer.
2/2019Apalutamide and its use in the treatment of prostate cancer.
12/2018Apalutamide in the treatment of castrate-resistant prostate cancer: evidence from clinical trials.
10/2018Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eric J Small Research Topics

Disease

234Prostatic Neoplasms (Prostate Cancer)
04/2022 - 02/2002
106Neoplasms (Cancer)
04/2022 - 06/2002
42Neoplasm Metastasis (Metastasis)
02/2022 - 08/2002
31Disease Progression
12/2018 - 08/2002
24Leukemia
10/2020 - 08/2002
20Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 04/2004
12Carcinoma (Carcinomatosis)
01/2021 - 12/2003
11Adenocarcinoma
12/2021 - 08/2002
9Pain (Aches)
11/2014 - 12/2003
8Fatigue
01/2022 - 03/2005
6Neutropenia
01/2022 - 12/2003
5Exanthema (Rash)
01/2021 - 03/2007
5Hypertension (High Blood Pressure)
01/2021 - 11/2008
4Melanoma (Melanoma, Malignant)
12/2020 - 04/2013
3Proteinuria
01/2021 - 11/2008
3Urinary Bladder Neoplasms (Bladder Cancer)
01/2019 - 07/2005
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2016 - 09/2002
3Margins of Excision
05/2008 - 08/2002
3Transitional Cell Carcinoma
10/2005 - 04/2003
2Febrile Neutropenia
01/2022 - 03/2005
2Carcinogenesis
07/2019 - 01/2018
2Hypoxia (Hypoxemia)
07/2019 - 04/2004
2Circulating Neoplastic Cells
12/2017 - 09/2017
2Diarrhea
01/2017 - 09/2012
2Cancer Pain
10/2015 - 01/2013

Drug/Important Bio-Agent (IBA)

79AndrogensIBA
02/2022 - 02/2002
54Prostate-Specific Antigen (Semenogelase)IBA
02/2022 - 06/2002
54Hormones (Hormone)IBA
01/2020 - 06/2002
30Docetaxel (Taxotere)FDA Link
01/2022 - 12/2003
22Prednisone (Sone)FDA LinkGeneric
01/2022 - 10/2004
21sipuleucel-T (APC8015)FDA Link
01/2021 - 06/2005
19Androgen Receptors (Androgen Receptor)IBA
01/2021 - 07/2003
19AntigensIBA
12/2020 - 02/2002
18Abiraterone AcetateIBA
01/2019 - 03/2010
17Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2002
14Bevacizumab (Avastin)FDA Link
01/2022 - 04/2004
12apalutamideIBA
02/2022 - 01/2018
12enzalutamideIBA
01/2022 - 05/2015
11Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
11/2016 - 01/2003
10Biological ProductsIBA
01/2019 - 01/2003
10EstramustineFDA Link
02/2011 - 12/2003
9Testosterone (Sustanon)FDA Link
08/2021 - 08/2002
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2012 - 04/2004
8Ketoconazole (Nizoral)FDA LinkGeneric
12/2014 - 08/2002
7abirateroneIBA
01/2022 - 01/2013
7Pharmaceutical PreparationsIBA
09/2021 - 06/2004
7GemcitabineFDA Link
01/2021 - 04/2003
7Tyrosine Kinase InhibitorsIBA
07/2019 - 09/2002
7prostatic acid phosphataseIBA
08/2015 - 10/2003
6Proteins (Proteins, Gene)FDA Link
01/2022 - 10/2003
6IpilimumabIBA
01/2021 - 03/2007
6Cisplatin (Platino)FDA LinkGeneric
01/2021 - 04/2003
6cabozantinibIBA
11/2019 - 02/2013
6gallium 68 PSMA-11IBA
06/2019 - 01/2017
6Mitoxantrone (Novantrone)FDA LinkGeneric
01/2017 - 10/2004
5Phenobarbital (Luminal)FDA Link
11/2021 - 01/2019
5RNA (Ribonucleic Acid)IBA
12/2020 - 08/2017
5taxaneIBA
01/2020 - 01/2006
5Interferon-alpha (Interferon Alfa)IBA
01/2014 - 04/2004
5ixabepilone (BMS 247550)FDA Link
06/2011 - 03/2005
5ErbB Receptors (EGF Receptor)IBA
09/2009 - 09/2002
5Gefitinib (Iressa)FDA Link
01/2008 - 09/2002
4Immune Checkpoint InhibitorsIBA
01/2021 - 10/2012
4Sunitinib (Sutent)FDA Link
11/2019 - 01/2017
4Hemoglobins (Hemoglobin)IBA
10/2019 - 04/2013
4AntibodiesIBA
01/2018 - 05/2006
4Monoclonal AntibodiesIBA
04/2013 - 07/2004
4Insulin-Like PeptidesIBA
07/2012 - 03/2007
4Suramin (Suramin Sodium)IBA
06/2006 - 08/2002
4Carboplatin (JM8)FDA LinkGeneric
10/2005 - 04/2003
4herbal preparation PC-SPESIBA
09/2005 - 02/2002
4Diphosphonates (Bisphosphonates)IBA
12/2003 - 05/2002
3DNA (Deoxyribonucleic Acid)IBA
11/2021 - 07/2019
3Alkaline PhosphataseIBA
10/2019 - 12/2003
3Cell-Free Nucleic AcidsIBA
01/2017 - 05/2015
3VaccinesIBA
09/2015 - 07/2006
3Estrogens (Estrogen)FDA Link
10/2009 - 05/2002
3Cancer VaccinesIBA
05/2007 - 10/2003
3Androgen Antagonists (Antiandrogens)IBA
04/2007 - 07/2003
3thiamine triphosphorate (TTP)IBA
07/2006 - 07/2004
2Circulating Tumor DNAIBA
01/2020 - 12/2017
2PlatinumIBA
01/2020 - 10/2005
2LigandsIBA
12/2019 - 03/2005
2Phosphotransferases (Kinase)IBA
12/2019 - 07/2019
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
07/2019 - 10/2007
2bicalutamide (Casodex)FDA LinkGeneric
05/2019 - 01/2019
2RadiopharmaceuticalsIBA
01/2019 - 12/2013
2Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2018 - 01/2017
2Dehydroepiandrosterone (DHEA)IBA
12/2017 - 10/2009
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2017 - 02/2013
2Opiate AlkaloidsIBA
10/2015 - 01/2013
2sargramostim (Leukine)FDA Link
09/2015 - 06/2006

Therapy/Procedure

123Therapeutics
04/2022 - 02/2002
114Castration
02/2022 - 08/2002
46Drug Therapy (Chemotherapy)
01/2021 - 09/2004
33Immunotherapy
01/2021 - 06/2003
15Prostatectomy (Retropubic Prostatectomy)
08/2021 - 06/2002
14Radiotherapy
01/2021 - 06/2002
8Aftercare (After-Treatment)
11/2021 - 11/2004
2Life Support Care
10/2015 - 11/2014